Central Mechanisms II: Pharmacology of Brainstem Pathways
Following systemic administration, centrally acting antitussive drugs are generally assumed to act in the brainstem to inhibit cough. However, recent work in humans has raised the possibility of suprapontine sites of action for cough suppressants. For drugs that may act in the brainstem, the specific locations, types of neurones affected, and receptor specificities of the compounds represent important issues regarding their cough-suppressant actions. Two medullary areas that have received the most attention regarding the actions of antitussive drugs are the nucleus of the tractus solitarius (NTS) and the caudal ventrolateral respiratory column. Studies that have implicated these two medullary areas have employed both microinjection and in vitro recording methods to control the location of action of the antitussive drugs. Other brainstem regions contain neurones that participate in the production of cough and could represent potential sites of action of antitussive drugs. These regions include the raphe nuclei, pontine nuclei, and rostral ventrolateral medulla. Specific receptor subtypes have been associated with the suppression of cough at central sites, including 5-HT1A, opioid (μ, κ, and δ), GABA-B, tachykinin neurokinin-1 (NK-1) and neurokinin-2, non-opioid (NOP-1), cannabi-noid, dopaminergic, and sigma receptors. Aside from tachykinin NK-1 receptors in the NTS, relatively little is known regarding the receptor specificity of putative antitussive drugs in particular brainstem regions. Our understanding of the mechanisms of action of antitussive drugs would be significantly advanced by further work in this area.
KeywordsNucleus Tractus Solitarii Cough Suppressant Antitussive Effect Brainstem Pathway Antitussive Drug
Unable to display preview. Download preview PDF.
- Chen CY, Bonham AC, Plopper CG, Joad JP (2003) Neuroplasticity in nucleus tractus solitarius neurons after episodic ozone exposure in infant primates. J Appl Physiol 94:819–827Google Scholar
- Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM (2002) Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 300:314–323PubMedCrossRefGoogle Scholar
- Kamei J, Ogawa M, Kasuya Y (1987b) Monoamines and the mechanisms of action of antitussive drugs in rats. Arch Int Pharmacodyn Ther 290:117–127Google Scholar
- Kamei J, Yoshikawa Y, Saitoh A (2006) Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice. Cough 2:2Google Scholar
- Korpas J, Tomori Z (1979) Cough and other respiratory reflexes. S. Karger, Basel, New YorkGoogle Scholar
- Rose MJ, Wang C, Golder FJ, Hammond JA, Bolser DC (2004) Influence of intrathecal and intra-arterial baclofen on laryngeal and tracheobronchial cough in the cat. FASEB J 18:A718Google Scholar
- Shannon R, Baekey DM, Morris KF, Li Z, Lindsey BG (2000) Functional connectivity among ven-trolateral medullary respiratory neurones and responses during fictive cough in the cat. J Physiol 525 Pt 1:207–224Google Scholar